Paper21288
Specific labeling of intracellular Toxoplasma gondii with uracil.
Pfefferkorn ER and 1 other. J Protozool, 1977. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Specific labeling of intracellular Toxoplasma gondii with uracil. Papers, record 21288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Toxoplasma | Major topic |
| Uracil | Major topic |
| Animals | |
| Autoradiography | |
| Cell Line | |
| DNA | |
| Hydrogen-Ion Concentration | |
| Kinetics | |
| RNA | |
| Uridine Phosphorylase |
Source PubMed
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41073664 | Toxoplasma gondii VIP1 mediates parasitophorous vacuole-host endoplasmic reticulum interactions to facilitate parasite development. | Nat Microbiol | 2025 | https://conductscience.org/library/papers/41073664 | PubMed |
| 39105673 | 1-Deoxy-d-xylulose 5-phosphate reductoisomerase as target for anti Toxoplasma gondii agents: crystal structure, biochemical characterization and biological evaluation of inhibitors. | Biochem J | 2024 | https://conductscience.org/library/papers/39105673 | PubMed |
| 39104777 | Synthesis and In vitro evaluation of bichalcones as novel anti-toxoplasma agents. | Front Chem | 2024 | https://conductscience.org/library/papers/39104777 | PubMed |
| 38162577 | Pyrimidine salvage in Toxoplasma gondii as a target for new treatment. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38162577 | PubMed |
| 37322556 | A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. | Infect Dis Poverty | 2023 | https://conductscience.org/library/papers/37322556 | PubMed |
| 36139955 | In Vitro Biological Activity of Natural Products from the Endophytic Fungus Paraboeremia selaginellae against Toxoplasma gondii. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36139955 | PubMed |
| 33335660 | Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/33335660 | PubMed |
| 33154954 | The Growth of Eimeria tenella: Characterization and Application of Quantitative Methods to Assess Sporozoite Invasion and Endogenous Development in Cell Culture. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33154954 | PubMed |
| 32420988 | Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay. | J Vis Exp | 2020 | https://conductscience.org/library/papers/32420988 | PubMed |
| 31267172 | Interplay between IDO1 and iNOS in human retinal pigment epithelial cells. | Med Microbiol Immunol | 2019 | https://conductscience.org/library/papers/31267172 | PubMed |
| 31119105 | Toxoplasma Hypervirulence in the Rat Model Parallels Human Infection and Is Modulated by the Toxo1 Locus. | Front Cell Infect Microbiol | 2019 | https://conductscience.org/library/papers/31119105 | PubMed |
| 30781494 | hCMV-Mediated Immune Escape Mechanisms Favor Pathogen Growth and Disturb the Immune Privilege of the Eye. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30781494 | PubMed |
| 30529548 | Global analysis of RNA metabolism using bio-orthogonal labeling coupled with next-generation RNA sequencing. | Methods | 2019 | https://conductscience.org/library/papers/30529548 | PubMed |
| 29998728 | Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro. | ACS Infect Dis | 2018 | https://conductscience.org/library/papers/29998728 | PubMed |
| 29874042 | Bioorthogonal Metabolic Labeling of Nascent RNA in Neurons Improves the Sensitivity of Transcriptome-Wide Profiling. | ACS Chem Neurosci | 2018 | https://conductscience.org/library/papers/29874042 | PubMed |
| 27600037 | Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27600037 | PubMed |
| 26838719 | Toxoplasma gondii Arginine Methyltransferase 1 (PRMT1) Is Necessary for Centrosome Dynamics during Tachyzoite Cell Division. | mBio | 2016 | https://conductscience.org/library/papers/26838719 | PubMed |
| 26272689 | Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells. | Parasit Vectors | 2015 | https://conductscience.org/library/papers/26272689 | PubMed |
| 25288090 | Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25288090 | PubMed |
| 25049241 | Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25049241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21288
GET https://conductscience.org/api/papers/v1/21288/cited_by?page=2